Browsing Category
S-4 Filing
961 posts
Ace Convergence Asks Shareholders for 3 1/2 Month Extension After Bumpy Road on Tempo Deal
The Ace trust is down to about $40 million in the wake of redemptions following the last two deadline extension votes.
August 30, 2022
Monterey Bio Acquisition is Latest SPAC to Seek Deadline Extension
The biotech-focused SPAC raised $115 million in an October 2021 IPO.
August 25, 2022
Trump-Tied SPAC Digital World Files Definitive Proxy on Year-Long Deadline Extension Proposal
If the proposal is not approved, Digital World says it will begin winding down.
August 25, 2022
Good Works Acquisition II Files Prelim Proxy for 6-Month Deadline Extension
The SPAC raised $200 million in a July 2021 IPO to target high-growth companies that need significant capital because of disruptions related to COVID-19 or other high-quality businesses experiencing high-growth.
August 24, 2022
Horizon Acquisition II Wants Deadline Extension to September 2023
Management in the filing said they are in preliminary discussions with a potential merger partner, but still need more time. The SPAC, led by Los Angeles Dodger co-owner Todd Boehly, ended discussions last year with Sportradar, a sports data provider.
August 24, 2022
Nocturne Acquisition Wants to Push Deadline Back by 6 Months
The SPAC raised $100 million in a March 2021 IPO with plans at that time to focus on targets bringing to market disruptive technologies in the blockchain/crypto and artificial intelligence technology sectors.
August 23, 2022
First Light Acquisition Group Sets Vote Next Month for Deadline Extension up to a Year
While the SPAC said it is "currently in discussions regarding various business combination opportunities," there won't be enough time to reach an agreement, much less complete a deal, before the current Sept. 14 deadline.
August 23, 2022
Bluescape Opportunities Acquisition Sets Vote Date on Proposal for 12-Month Deadline Extension
Bluescape is focused on businesses in energy infrastructure and related sectors.
August 23, 2022
SPAC Warns Success of Trump Media Hinges on Trump’s Popularity
"Adverse reactions to publicity relating to Trump, or the loss of his services, could adversely affect TMTG’s revenues, results of operations and its ability to maintain or generate a consumer base, as well as the outcome of the proposed business combination," the filing states.
August 22, 2022
Jatt Acquisition Files Prelim Proxy on Zura Bio Deal
The combined company is expected to receive gross cash proceeds of up to $189 million, which includes the $139 million held in JATT’s trust account (less any redemptions) and a concurrent, fully-committed $50 million from a forward purchase agreement and PIPE financing.
August 22, 2022